E-LIB Suche - Ergebnisse für: Torella, Laura

1

Efficient and safe therapeutic use of paired Cas9-nickases ..:

Torella, Laura ; Klermund, Julia ; Bilbao-Arribas, Martin...
EMBO Molecular Medicine. 16 (2024) 1 - p. 112-131 , 2024

Link: https://doi.org/10.1038/..

2

Protective role of RIPK1 scaffolding against HDV-induced he..:

Camps, Gracián ; Maestro, Sheila ; Torella, Laura...
PLOS Pathogens. 20 (2024) 5 - p. e1011749 , 2024

Link: https://doi.org/10.1371/..

3

mRNA and gene editing: Late breaking therapies in liver dis..:

Zabaleta, Nerea ; Torella, Laura ; Weber, Nicholas D..
Hepatology. 76 (2022) 3 - p. 869-887 , 2022

Link: https://doi.org/10.1002/..

4

Differential Trafficking and Expression of PIR Proteins in ..:

Giorgalli, Maria ; Cunningham, Deirdre A. ; Broncel, Malgorzata...
Frontiers in Cellular and Infection Microbiology. 12 (2022) - p. , 2022

Link: https://doi.org/10.3389/..

5

In Vitro and In Vivo Genetic Disease Modeling via NHEJ-Prec..:

López-Manzaneda, Sergio ; Ojeda-Pérez, Isabel ; Zabaleta, Nerea...
Molecular Therapy - Methods & Clinical Development. 19 (2020) - p. 426-437 , 2020

Link: https://doi.org/10.1016/..

6

CRISPR/Cas9-mediated glycolate oxidase disruption is an eff..:

Zabaleta, Nerea ; Barberia, Miren ; Martin-Higueras, Cristina...
Nature Communications. 9 (2018) 1 - p. , 2018

Link: https://doi.org/10.1038/..

7

Progress and harmonization of gene editing to treat human d..:

Cavazza, Alessia ; Hendel, Ayal ; Bak, Rasmus O....
Molecular Therapy - Nucleic Acids. 34 (2023) - p. 102066 , 2023

Link: https://doi.org/10.1016/..

8

Expanding Phenotype of Poirier–Bienvenu Syndrome: New Evide..:

Orsini, Alessandro ; Santangelo, Andrea ; Bravin, Francesca...
Genes. 13 (2022) 2 - p. 276 , 2022

Link: https://doi.org/10.3390/..

9

A Rare Case of Severe Congenital RYR1-Associated Myopathy:

Laforgia, Nicola ; Capozza, Manuela ; De Cosmo, Lucrezia...
Case Reports in Genetics. 2018 (2018) - p. 1-7 , 2018

Link: https://doi.org/10.1155/..

10

Progress and harmonization of gene editing to treat human d..:

Alessia Cavazza ; Ayal Hendel ; Rasmus O. Bak...
http://www.sciencedirect.com/science/article/pii/S2162253123002846. , 2023

Link: https://doi.org/10.1016/..

11

mRNA and gene editing: Late breaking therapies in liver dis..:

Zabaleta-Lasarte, N. (Nerea) ; Torella, L. (Laura) ; Weber, N.D. (Nicholas D.).
info:eu-repo/grantAgreement/AEI/Retos Investigación: Proyectos I+D+i/RTI2018-101936-B-I00/ES/ANALISIS DE LA INTERACION DEL VIRUS DE LA HEPATITIS DELTA (HDV) CON EL HOSPEDADOR Y CON EL VIRUS DE LA HEPATITIS B (HBV). , 2022

Link: https://hdl.handle.net/1..

12

Differential Trafficking and Expression of PIR Proteins in ..:

Giorgalli, Maria ; Cunningham, Deirdre A ; Broncel, Malgorzata...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9245118/. , 2022

Link: http://www.ncbi.nlm.nih...

13

In Vitro and In Vivo Genetic Disease Modeling via NHEJ-Prec..:

López-Manzaneda, Sergio ; Ojeda-Pérez, Isabel ; Zabaleta, Nerea...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683234/. , 2020

Link: http://www.ncbi.nlm.nih...

14

In Vitro and In Vivo Genetic Disease Modeling via NHEJ-Prec..:

López-Manzaneda, S. (Sergio) ; Ojeda-Pérez, I. (Isabel) ; Zabaleta-Lasarte, N. (Nerea)...
info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016/SAF2017-84248-P/ES/TERAPIA GENICA PARA LA DEFICIENCIA EN PIRUVATO QUINASA: DEMOSTRACION DEFINITIVA DE LA EFICACIA DE LA TERAPIA GENICA DE ADICION Y ESTABLECIMIENTO DE ESTRATEGIAS EDICION GENICA. , 2020

Link: https://hdl.handle.net/1..

15

CRISPR/Cas9-mediated glycolate oxidase disruption is an eff..:

Zabaleta-Lasarte, N. (Nerea) ; Barberia, M. (Miren) ; Martin-Higueras, C. (Cristina)...
https://hdl.handle.net/10171/56384. , 2018

Link: https://hdl.handle.net/1..